CID 11311685

4,4,5,5-tetramethyl-2-[(tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]-1,3,2-dioxaborolane

Structural Information

Molecular Formula
C13H26B2O4
SMILES
B1(OC(C(O1)(C)C)(C)C)CB2OC(C(O2)(C)C)(C)C
InChI
InChI=1S/C13H26B2O4/c1-10(2)11(3,4)17-14(16-10)9-15-18-12(5,6)13(7,8)19-15/h9H2,1-8H3
InChIKey
MQYZGGWWHUGYDR-UHFFFAOYSA-N
Compound name
4,4,5,5-tetramethyl-2-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl]-1,3,2-dioxaborolane
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

240
Patents

268.20172 Da
Monoisotopic Mass

None
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 269.20900 144.6
[M+Na]+ 291.19094 154.2
[M-H]- 267.19444 154.4
[M+NH4]+ 286.23554 167.9
[M+K]+ 307.16488 157.9
[M+H-H2O]+ 251.19898 145.3
[M+HCOO]- 313.19992 161.5
[M+CH3COO]- 327.21557 198.7
[M+Na-2H]- 289.17639 152.1
[M]+ 268.20117 151.6
[M]- 268.20227 151.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe